COLLIER ALAN BRIAN (CEO) purchased 1.5% of their position (400.00 shares) of ENDONOVO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $40.98 — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 7/7/2020ACC: 0001645470-20-000005
Officer· CEO
Since Jun 2016
+400.00
Net shares
Net buyer
$40.98
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
400.00 acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+200.00
Price / share
$0.10
Trade value
$20.70
% of position
0.8%
6/30/2020
25.82K→26.02K
Common Stock
Direct
Shares
+100.00
Price / share
$0.10
Trade value
$10.04
% of position
0.4%
7/1/2020
26.02K→26.12K
Common Stock
Direct
Shares
+100.00
Price / share
$0.10
Trade value
$10.24
% of position
0.4%
7/1/2020
26.12K→26.22K
Total
Net shares
+400.00
Net value
$40.98
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2020 | P · Purchase | +200.00 | $0.10 | $20.70 | 0.8% | 25.82K | 26.02K |
| Common Stock Direct | 7/1/2020 | P · Purchase | +100.00 | $0.10 | $10.04 | 0.4% | 26.02K | 26.12K |
| Common Stock Direct | 7/1/2020 | P · Purchase | +100.00 | $0.10 | $10.24 | 0.4% | 26.12K | 26.22K |
| Total | +400.00 | $40.98 | ||||||
Derivative Transactions0
No derivative transactions reported